GenSight will participate to the 2019 Annual Meeting of the American Society for Retina Specialists (ASRS) in Chicago, IL (US), from 26-30 July 2019.

One poster will present GS030, our lead gene therapy product candidate, an innovative optogenetic treatment that started a Phase I/II PIONEER clinical trial in Europe and US with patients affected by Retinitis Pigmentosa (RP).

GS030 – Optogenetics in Retinitis Pigmentosa (RP)

E-poster presentation and Scientific Poster

Title –  THE PIONEER STUDY brings Optogenetics to the Clinic:  a Phase 1/2 Gene Therapy Program for Non-Syndromic Retinitis Pigmentosa

  • Scientific poster will be displayed Saturday through Tuesday
  • Q&A session with presence of the poster author:  Monday, July 29 – 3:35-4:35 PM CST
  • Poster Author: Joseph Martel, MD, Assistant Professor of Ophthalmology Retina and Vitreous Servious, UPMC Eye Center – Eye & Ear Institute, Pittsburg, PA (US)